Platelet Procoagulant Activity During,Peripheral Blood Stem Cell Harvest

Clinical and Applied Thrombosis/Hemostasis

Volumn 3, Issue 2, 1997, Pages 124-128

  Katsura, Kaoruko ^a   Nomura, Shosaku ^a   Lan Xie, Gui ^a   Ohtani, Tetsuji ^a   Ishida, Tomoko ^a   Kagawa, Hideo ^a   Kitada, Chikaho ^a   Yamanaka, Yoshitaka ^a   Kitajima, Hiroyuki ^a   Fukuhara, Shirou ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Granulocyte colony stimulating factor; Peripheral blood stem cell harvest; Platelet derived microparticle

Indexed keywords

EID: 84996192208     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969700300210     Document Type: Article

References (43)

1. Juttner CA, To LB, Haylock DN, et al. Autologous blood stem cell transplantation. Transplant Proc 1989; 21: 2929-31.
2. Haas R., Ho AD, Bredthauer U., et al. Successful autologous transplantation of blood stem cells mobilized with recombinant human granutocyte-macrophage colony-stimulating factor. Exp Hematol 1990; 18: 94-98.
3. Elias AD, Ayash L., Anderson KC, et al. Mobilization of peripheral blood progenitor cells by chemotherapy and granulocyte-macrophage colony-stimulating factor for hematologic support after high-dose intensification in breast cancer. Blood 1992; 79: 3036-44.
4. Brugger W., Bross KJ, Frisch J., et al. Mobilization of peripheral blood progenitor cells by sequential administration of IL-3 and GM-CSF following polychemotherapy with etoposide, ifosfamide, and cisplatin. Blood 1992; 79: 1193-200.
5. Sheridan WP, Begley CG, Juttner C., et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 1992; 339: 640-4.
6. Tepler I., Cannistra SA, Gonin R., et al. Use of peripheral blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy. J Clin Oncol 1993; 11: 1583-91.
7. Abrams CS, Shattil SJ Immunolojical detection of activated platelets in clinical disorders. Thromb Haemost 1991; 65: 467-73.
8. Sims PJ, Faioni EM, Wiedmer T., Shattil SJ Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. J Biol Chem 1988; 263: 18205-12.
9. Nomura S., Yanabu M., Kido H. et al. Antiplatelet auto-antibody-related microparticles in patients with idiopathic (autoimmune) thrombocytopenic purpura. Ann Hematol 1991; 62: 103-7.
10. Nomura S., Yanabu M. Fukuroi T., et al. Antiphospholipid antibodies bind to platelet microparticles in idiopathic (autoimmune) thrombocytopenic purpura. Ann Hematol 1992; 65: 46-49.
11. Nomura S., Yanabu M., Miyake T., et al. Relationship of microparticles with β2-glycoprotein I and P-selectin positivity to anticardiolipin antibodies in immune thrombocytopenic purpura. Ann Hematol 1995; 70: 25-30.
12. Nomura S., Yanabu M., Kido H., et al. Significance of cytokines and CD68-positive microparticles in immune thrombocytopenic purpura. Eur J Haematol 1995; 55: 49-56.
13. Nomura S., Shouzu A., Nishikawa M., Kokawa T., Yasunaga K. Significance of platelet-derived microparticles in uremia. Nephron 1993; 63: 485.
14. Nomura S., Komiyama Y., Miyake T., et al. Amyloid β-protein precursor-rich platelet microparticles in thrombotic disease. Thromb Haemost 1994;72: 519-22.
15. Nomura S., Suzuki M., Katsura K., et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis 1995; 116: 235-40.
16. Abrams CS, Ellison N., Budzynski AZ, Shattil SJ Direct detection of activated platelets and platelet-derived microparticles in humans. Blood 1990; 75: 128-38.
17. Bender JG, Unverzagt K., Walker D. Guidelines for determination of CD34+ cells by flow cytometry: application to the harvesting and transplantation of peripheral blood stem cells. In: Wunder E, Sovalat H, Henon P, et al., eds. Hematopoietic stem cells: the Mulhouse manual. Dayton, OH: Alpha Med Press, 1994:31-43.
18. Civin CL Summary of CD34 Cluster Workshop Section. In: Knapp W, ed. Leukocyte typing IV. London: Academic Press, 1989: 818-25.
19. Mercolino TJ, Connelly MC, Meyer EJ, et al. Immunologic differentiation of absolute lymphocyte count with an integrated flow cytometric system: a new concept for absolute T cell subset determinations. Cytometry 1995; 22: 48-59.
20. Nomura S., Miyazaki Y., Miyake T., et al. IgG inhibits the increase of platelet-associated C3 stimulated by anti-platelet antibodies. Clin Exp Immunol 1993; 93: 452-5.
21. Nomura S., Suzuki M., Kido H., et al. Differences between platelet and microparticle glycoprotein IIb/IIIa. Cytometry 1992; 13: 621-9.
22. Berndt MC, Du X., Booth WJ Ristocetin-dependent reconstitution of binding of von Willebrand factor to purified human platelet membrane glycoprotein Ib-IX complex. Biochemistry 1988; 27: 633-40.
23. Dachary-Prigent J., Freyssinet JM, Pasquet JM, Carron JC, Nurden AT Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993;81: 2554-65.
24. Shimoda K., Okumura S., Harada N., Kondo S., Okamura T., Niho Y. Identification of a functional receptor for granulocyte colony-stimulating factor on platelets. J Clin Invest 1993; 91: 1310-3.
25. Oleksowiez L., Mrowiec Z., Zuckerman D., Isaacs R., Dutcher J., Puszkin E. Platelet activation induced by interleukin-6: evidence for a mechanism involving arachidonic acid metabotism. Thromb Haemost 1994; 72: 302-8.
26. 26, Grabarek J., Groopman JE, Lyles YR, et al: Human kit ligand (stem cell factor) modulates platelet activation in vitro. J Biol Chem 1994: 269: 21718-24.
27. de Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994; 369: 533-8.
28. Kaushansky K., Lok S., Holly RD, et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994; 369: 568-71.
29. Wndling FW, Maraskovsky E., Debili N., et al. Nature 1994; 369: 571-4.
30. Kojima H., Hamazaki Y., Nagata Y., Todokoro K., Nagasawa T., Abe T. Modulation of platelet activation in vitro by thrombopoietin. Thromb Haemost 1995; 74: 1541-5.
31. Shimoda K., Okamura S., Inaba S., et al. Granulocyte colony-stimulating factor and platelet aggregation [Letter]. Lancet 1993; 341: 633.
32. Fox Jeb, Austin CD, Reynolds CC, Steffen PK Evidence that agonist-induced activation of calpain causes the shedding of procoagulant-containing microvesicles from the membrane of aggregating platelets. J Biol Chem 1991; 266: 13289-95.
33. Zwaal Rfa, Comfurius P., Bevers EM Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis. Biochem Biophys Acta 1992; 1180: 1-8.
34. Sims PJ, Wiedmer T., Esmon CT, Weiss HJ, Shattil SJ Assembly of platelet prothrombinase complex is linked to vesiculation of the platelet plasma membrane. Studies in Scott syndrome: an isolated defect in platelet procoagulant activity. J Biol Chem 1989; 264. 17049-59.
35. Holme PA, Brosstad F., Solum NO Platelet-derived microvesicles and activated platelets express factor Xa activity. Blood Coagul Fibrinolysis 1995;6: 302-310.
36. Jy W., Horstman L., Arce M., Ahn YS Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992; 119: 334-45.
37. Holme PA, Solum NO, Brosstad F., Roger M., Abdelnoor M. Demonstration of platelet-derived microvesicles in blood from patients with activated coagulation and fibrinolysis using a filtration technique and Western blotting. Thromb Haemost 1994; 72: 666-71.
38. Gemmell CH, Sefton MV, Yeo EL Platelet-derived microparticle formation involves glycoprotein IIb-IIIa: Inhibition by RGDS and a Glanzmann's thrombasthenia defect. J Biol Chem 1993; 268: 14586-9.
39. Holme PA, Solum NO, Brosstad F., Egberg N., Lindahl TL Stimulated Glanzmann's thrombasthenia platelets produce microvesicles. Microvesiculation correlates better to exposure of procoagulant surface than to activation of GPIIb-IIIa. Thromb Haemost 1995; 74: 1533-40.
40. Nomura S., Komiyama Y., Matsuura E., et al. Participation of αIIbβ3 in platelet microparticle generation by collagen plus thrombin. Haemostasis 1996;26: 31-37.
41. Thiagarajan P., Tait JF Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 1991; 266. 24302-7.
42. Kessinger A., Armitage JO The evolving role of autologous peripheral stem cell transplantation following high-dose therapy for malignancies. Blood 1991; 77: 211-3.
43. Ruse-Riol F., Legros M., Bernard D., et al. Variations in committed stem cells (CFU-GM and CFU-TL) in the peripheral blood of cancer patients treated by sequential combination chemotherapy for breast cancer. Cancer Res 1984; 44: 2219-24.